Research Letters15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children
References (5)
- et al.
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV-1 in breastfed in children in Côte d'Ivoire and Burkina Faso; a double-blind placebo-controlled multicentre trial
Lancet
(1999) - et al.
Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial
Lancet
(1999)
There are more references available in the full text version of this article.
Cited by (49)
Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): A randomised, double-blind, placebo-controlled trial
2002, LancetCitation Excerpt :At month 18 there is still a difference in efficacy between the study groups, but for breastfed children the difference is then no longer statistically significant. In the Ditrame study13 done in Côte d'Ivoire and Burkina Faso, in a breastfeeding population, after 15 months of follow-up, HIV-1 transmission rates were still significantly better in the short-course zidovudine group than in the placebo group.29 Infections continued to occur, however, in that study, in both the original zidovudine and placebo group, at each time period tested after week 6.
Preventing mother-to-child transmission of HIV in resource-limited settings
2009, Future VirologyEfficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: A meta-analysis of published clinical trials
2008, AIDS Research and Human Retroviruses
Members listed in
Copyright © 1999 Elsevier Ltd. All rights reserved.